HIV-1 reverse transcriptase stability correlates with Gag cleavage efficiency: reverse transcriptase interaction implications for modulating protease activation

被引:0
|
作者
Hsieh, Shih-Han [1 ,2 ]
Yu, Fu-Hsien [1 ,2 ]
Huang, Kuo-Jung [1 ]
Wang, Chin-Tien [1 ,2 ]
机构
[1] Taipei Vet Gen Hosp, Dept Med Res, Div Clin Res, Taipei, Taiwan
[2] Natl Yang Ming Chiao Tung Univ, Inst Clin Med, Hsinchu, Taiwan
关键词
HIV; retroviruses; reverse transcriptase; IMMUNODEFICIENCY-VIRUS TYPE-1; TRYPTOPHAN REPEAT MOTIF; DIMERIZATION; MATURATION; MUTATIONS; POLYPROTEIN; PR160(GAG-POL); PR160GAG-POL; EXPRESSION; INHIBITORS;
D O I
暂无
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Proteolytic processing of human immunodeficiency virus type 1 particles mediated by viral protease (PR) is essential for acquiring virus infectivity. Activation of PR embedded in Gag-Pol is triggered by Gag-Pol dimerization during virus assembly. We previously reported that amino acid substitutions at the RT tryptophan repeat motif destabilize virus-associated RT and attenuate the ability of efavirenz (EFV, an RT dimerization enhancer) to increase PR-mediated Gag cleavage efficiency. Furthermore, a single amino acid change at RT significantly reduces virus yields due to enhanced Gag cleavage. These data raise the possibility of the RT domain contributing to PR activation by promoting Gag-Pol dimerization. To test this hypothesis, we investigated the putative involvement of a hydrophobic leucine repeat motif (LRM) spanning RT L282 to L310 in RT/RT interactions. We found that LRM amino acid substitutions led to RT instability and that RT is consequently susceptible to degradation by PR. The LRM mutants exhibited reduced Gag cleavage efficiencies while attenuating the EFV enhancement of Gag cleavage. In addition, an RT dimerization-defective mutant, W401A, reduced enhanced Gag cleavage via a leucine zipper (LZ) motif inserted at the deleted Gag-Pol region. Importantly, the presence of RT and integrase domains failed to counteract the LZ enhancement of Gag cleavage. A combination of the Gag cleavage enhancement factors EFV and W402A markedly impaired Gag cleavage, indicating a disruption of W402A Gag-Pol dimerization following EFV binding to W402A Gag-Pol. Our results support the idea that RT modulates PR activation by affecting Gag-Pol/Gag-Pol interaction.
引用
收藏
页数:16
相关论文
共 50 条
  • [21] FIDELITY OF HIV-1 REVERSE-TRANSCRIPTASE
    PRESTON, BD
    POIESZ, BJ
    LOEB, LA
    SCIENCE, 1988, 242 (4882) : 1168 - 1171
  • [22] An overview on HIV-1 reverse transcriptase inhibitors
    Ravichandran, Shalini
    Veerasamy, Ravichandran
    Raman, Saraswathi
    Krishnan, Palamadai Neelakandam
    Agrawal, Ram Kishore
    DIGEST JOURNAL OF NANOMATERIALS AND BIOSTRUCTURES, 2008, 3 (04) : 171 - 187
  • [23] Peptide-based inhibitors of HIV-1 reverse transcriptase activation
    Agopian, Audrey
    Bosquet-Dereuddre, Nathalie
    Clayette, Pascal
    Gros, Edwige
    Divita, Gilles
    BIOPHYSICAL JOURNAL, 2007, : 512A - 512A
  • [24] Interaction of HIV-1 Reverse Transcriptase Ribonuclease H with an Acylhydrazone Inhibitor
    Gong, Qingguo
    Menon, Lakshmi
    Ilina, Tatiana
    Miller, Lena G.
    Ahn, Jinwoo
    Parniak, Michael A.
    Ishima, Rieko
    CHEMICAL BIOLOGY & DRUG DESIGN, 2011, 77 (01) : 39 - 47
  • [25] Vertical transmission of HIV-1 variants resistant to reverse transcriptase and protease inhibitors
    De Jose, MI
    Ramos, JT
    Alvarez, S
    Jimenez, JL
    Muñoz-Fernández, MA
    ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (22) : 2738 - 2739
  • [26] INTERACTION OF FLUORESCENTLY LABELED DIDEOXYNUCLEOTIDES WITH HIV-1 REVERSE-TRANSCRIPTASE
    MULLER, B
    RESTLE, T
    REINSTEIN, J
    GOODY, RS
    BIOCHEMISTRY, 1991, 30 (15) : 3709 - 3715
  • [27] Interplay between protease and reverse transcriptase dimerization in a model HIV-1 polyprotein
    Chagas, Brisa Caroline Alves
    Zhou, Xiaohong
    Guerrero, Michel
    Ilina, Tatiana V.
    Ishima, Rieko
    PROTEIN SCIENCE, 2024, 33 (07)
  • [28] Substrate requirements for secondary cleavage by HIV-1 reverse transcriptase RNase H
    Wisniewski, M
    Chen, Y
    Balakrishnan, M
    Palaniappan, C
    Roques, BP
    Fay, PJ
    Bambara, RA
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (32) : 28400 - 28410
  • [29] SPECTROSCOPIC STUDIES OF THE INTERACTION OF NEVIRAPINE WITH HIV-1 REVERSE-TRANSCRIPTASE
    GRYGON, CA
    COUSINS, RC
    GREENWOOD, DJ
    INGRAHAM, RH
    WARREN, TC
    MCGOFF, P
    STEVENSON, J
    BIOPHYSICAL JOURNAL, 1993, 64 (02) : A54 - A54
  • [30] Inhibitors from Natural Products to HIV-1 Reverse Transcriptase, Protease and Integrase
    Jiang, Y.
    Ng, T. B.
    Wang, C. R.
    Zhang, D.
    Cheng, Z. H.
    Liu, Z. K.
    Qiao, W. T.
    Geng, Y. Q.
    Li, N.
    Liu, F.
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2010, 10 (14) : 1331 - 1344